ClinConnect ClinConnect Logo
Search / Trial NCT01677221

Effects of Acleara Needle Insert on Acne

Launched by THERAVANT CORPORATION · Aug 29, 2012

Trial Information

Current as of May 23, 2025

Completed

Keywords

Acne Inflammatory Acne Intense Pulsed Light

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects \>14 years of age
  • Subject has mild to moderate acne vulgaris on the face, chest or back.
  • Subject has one or more inflammatory acne lesions on face, chest or back.
  • Willingness to participate in the study
  • Informed consent agreement signed by the subject
  • Willingness to follow the treatment schedule and post treatment care requirements
  • Willingness to remain on current acne therapy as directed by the Investigator.
  • Exclusion Criteria:
  • Subject has an infection or other dermatologic condition (aside from acne) in the area to be treated
  • Subject is immunosuppressed
  • Subject is unable to comply with treatment or follow-up visits
  • Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

About Theravant Corporation

Theravant Corporation is a biopharmaceutical company dedicated to advancing innovative therapies that address unmet medical needs across various therapeutic areas. With a strong focus on clinical research and development, Theravant harnesses cutting-edge science and technology to develop novel treatments aimed at improving patient outcomes. Committed to collaboration and ethical practices, the company engages with healthcare professionals, patients, and stakeholders to ensure that its clinical trials are designed to generate meaningful data and drive forward the next generation of healthcare solutions.

Locations

Bellaire, Texas, United States

White Plains, Maryland, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials